BREAST CANCER

🎗️ Breast Cancer: Understanding Diagnosis and Treatment Options

Breast cancer is a complex disease characterized by the abnormal and uncontrollable growth of cells in the breast, forming a lump or mass. This mass can invade nearby tissues or spread (metastasize) to other parts of the body.

🧬 1. What Is Breast Cancer?

Breast cancer typically originates in one of two main areas:

• Ducts: The passages that carry milk to the nipple (Ductal Carcinoma) — this is the most common type.
• Lobules: The glands that produce milk (Lobular Carcinoma).

Molecular Subtypes:

Cancers are classified by their receptor status, which dictates treatment:

• Hormone-Sensitive: Estrogen (ER) or Progesterone (PR) receptor–positive.
• HER2-Positive: Overexpression of the HER2 protein.
• Triple-Negative: Lacking all three markers (ER, PR, HER2); these often require a more aggressive treatment approach.

🔍 2. How Breast Cancer Is Diagnosed

A. Screening (For Early Detection)

• Mammogram: An X-ray of the breast used for early detection, especially recommended for women over 40 years.
• Breast self-exam or clinical breast exam: Physically checking for lumps, changes in skin texture, or nipple discharge.

B. Diagnostic Tests (If an Abnormality Is Found)

1. Ultrasound: Used to determine if a suspected lump is solid or fluid-filled (cyst).
2. Diagnostic Mammogram: Provides more detailed imaging of a specific suspicious area.
3. MRI of the Breast: Used for high-risk women or to comprehensively assess the extent of the tumor.
4. Biopsy (Definitive Test): This is the most definitive test. A small tissue sample is removed (via core needle or surgery) for lab analysis.
   • Purpose: Determines the cancer type, grade, and the crucial receptor status (ER/PR/HER2).

C. Staging

Once cancer is confirmed, further imaging (CT scan, PET scan, bone scan) determines if it has spread. Stages range from **0 (in situ)** to **IV (metastatic)**.

💊 3. Treatment Methods

Treatment is highly personalized, based on the cancer type, stage, receptor status, and the patient’s overall health and preference.

A. Surgery

• Lumpectomy: (Breast-conserving surgery) Removes the tumor and a small margin of surrounding tissue.
• Mastectomy: Removes the entire breast.
• Lymph Node Procedure: Sentinel node biopsy or axillary dissection is performed to check for lymph node spread.

B. Radiation Therapy

Uses high-energy rays to destroy remaining cancer cells in the breast or chest area. It usually follows a **lumpectomy** and is sometimes used after a mastectomy for high-risk cases.

C. Chemotherapy

Uses powerful anti-cancer drugs to kill fast-growing cells throughout the body.

• Neoadjuvant: Given **before surgery** to shrink large tumors.
• Adjuvant: Given **after surgery** to prevent recurrence.

D. Hormone (Endocrine) Therapy

Used specifically for hormone receptor-positive cancers by blocking the effects of estrogen or lowering estrogen levels.

• Tamoxifen: Typically used for **premenopausal women**.
• Aromatase Inhibitors (letrozole, anastrozole): Typically used for **postmenopausal women**.

This therapy may continue for **5–10 years** to significantly prevent recurrence.

E. Targeted Therapy

Uses drugs that target specific vulnerabilities in cancer cells:

• HER2-positive cancers: Targeted by drugs like **Trastuzumab (Herceptin)** and **Pertuzumab**.
• PARP inhibitors: Used for specific genetically mutated cancers (e.g., **BRCA-mutated**).

F. Immunotherapy

Boosts the body’s own immune system to fight the cancer. It is mainly used for aggressive types like **triple-negative breast cancer** (e.g., **pembrolizumab**).

G. Supportive / Integrative Care

Holistic care including **pain management**, **counseling**, **physiotherapy** (especially for arm swelling/lymphedema), and **emotional support**.

---

🌸 4. Early Detection Saves Lives

Regular screening is the most powerful tool for improving outcomes:

• **Women 40–54:** **Annual mammogram** is highly recommended.
• **Women 55+:** Screening every **1–2 years** (if not high risk).
• **High-risk women** (e.g., strong family history, **BRCA1/2 mutation**): Should start screening **earlier** and often include a **Breast MRI**.